The pharmaceutical, chemical and polymer industries are cornerstones of Europe’s economy. A key element for their transition to more sustainable processes and to innovative new compounds is biocatalysis. Of particular interest are metallo-enzymes, i.e. proteins that host a metal cofactor.
As part of the MSCA network MetRaZymes, research studies will be performed at the Institute of Biochemical Engineering (IBVT) that aim to engineer and apply robust enzyme production hosts that are well prepared for large scale production without loss of performance. Investigations will comprise Escherichia coli engineering and application in so-called scale-down reactors to quantify the strain performance under industry-like process conditions.
PhD candidates should offer a proactive attitude for problem solution. You should have a profound background in molecular biology, microbiology, and biochemical engineering loving to apply said knowhow for strain engineering, testing, and quantitative analysis. Ideally, you are trained as a master of science or master of engineering with particular skills in ‘Chemical and Biochemical Engineering’, ‘Bioengineering’, ‘Biotechnology’, ‘Technical Biology’ or similar programs. The total of 141,919,2 € as living and mobility allowance will be paid for the 3 years project representing full employment at the University of Stuttgart, IBVT.
Candidates should provide a letter of motivation for the specific research project, a CV and publication list, contact details of two professional references, as well as copies of their degree certificates. The research project will start in April 2023.
Application deadline: 18th December 2022
Applications should be send to the PI:
Prof. Dr.-Ing. Ralf Takors
Institut für Bioverfahrenstechnik (IBVT) / Institute of Biochemical Engineering
Allmandring 31
70569 Stuttgart
E-Mail: takors@ibvt.uni-stuttgart.de